These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32608232)

  • 61. An overview of process development for antibody-drug conjugates produced by chemical conjugation technology.
    Matsuda Y; Mendelsohn BA
    Expert Opin Biol Ther; 2021 Jul; 21(7):963-975. PubMed ID: 33141625
    [No Abstract]   [Full Text] [Related]  

  • 62. High-Resolution Accurate-Mass Mass Spectrometry Enabling In-Depth Characterization of in Vivo Biotransformations for Intact Antibody-Drug Conjugates.
    He J; Su D; Ng C; Liu L; Yu SF; Pillow TH; Del Rosario G; Darwish M; Lee BC; Ohri R; Zhou H; Wang X; Lu J; Kaur S; Xu K
    Anal Chem; 2017 May; 89(10):5476-5483. PubMed ID: 28429938
    [TBL] [Abstract][Full Text] [Related]  

  • 63. AJICAP: Affinity Peptide Mediated Regiodivergent Functionalization of Native Antibodies.
    Yamada K; Shikida N; Shimbo K; Ito Y; Khedri Z; Matsuda Y; Mendelsohn BA
    Angew Chem Int Ed Engl; 2019 Apr; 58(17):5592-5597. PubMed ID: 30854738
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cutting-edge mass spectrometry methods for the multi-level structural characterization of antibody-drug conjugates.
    Beck A; Terral G; Debaene F; Wagner-Rousset E; Marcoux J; Janin-Bussat MC; Colas O; Van Dorsselaer A; Cianférani S
    Expert Rev Proteomics; 2016; 13(2):157-83. PubMed ID: 26653789
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A new anti-human Fc method to capture and analyze ADCs for characterization of drug distribution and the drug-to-antibody ratio in serum from pre-clinical species.
    Excoffier M; Janin-Bussat MC; Beau-Larvor C; Troncy L; Corvaia N; Beck A; Klinguer-Hamour C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():149-154. PubMed ID: 27267073
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hyphenation of size exclusion chromatography to native ion mobility mass spectrometry for the analytical characterization of therapeutic antibodies and related products.
    Ehkirch A; Hernandez-Alba O; Colas O; Beck A; Guillarme D; Cianférani S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jun; 1086():176-183. PubMed ID: 29684909
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Future of Antibody Drug Conjugation by Comparing Various Methods of Site-Specific Conjugation.
    Okojie J; McCollum S; Barrott J
    Discov Med; 2023 Dec; 35(179):921-927. PubMed ID: 38058056
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Understanding the Effects of Site-Specific Light Chain Conjugation on Antibody Structure Using Hydrogen Exchange-Mass Spectrometry (HX-MS).
    Karunaratne SP; Moussa EM; Mills BJ; Weis DD
    J Pharm Sci; 2024 May; ():. PubMed ID: 38761863
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cation exchange chromatography on a monodisperse 3 µm particle enables extensive analytical similarity assessment of biosimilars.
    Füssl F; Millán-Martín S; Bones J; Carillo S
    J Pharm Biomed Anal; 2023 Sep; 234():115534. PubMed ID: 37343453
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Universal Affinity Capture Liquid Chromatography-Mass Spectrometry Assay for Evaluation of Biotransformation of Site-Specific Antibody Drug Conjugates in Preclinical Studies.
    Kotapati S; Passmore D; Yamazoe S; Sanku RKK; Cong Q; Poudel YB; Chowdari NS; Gangwar S; Rao C; Rangan VS; Cardarelli PM; Deshpande S; Strop P; Dollinger G; Rajpal A
    Anal Chem; 2020 Jan; 92(2):2065-2073. PubMed ID: 31860282
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Online coupling of analytical hydrophobic interaction chromatography with native mass spectrometry for the characterization of monoclonal antibodies and related products.
    Yan Y; Xing T; Wang S; Daly TJ; Li N
    J Pharm Biomed Anal; 2020 Jul; 186():113313. PubMed ID: 32371326
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Development of a native nanoelectrospray mass spectrometry method for determination of the drug-to-antibody ratio of antibody-drug conjugates.
    Chen J; Yin S; Wu Y; Ouyang J
    Anal Chem; 2013 Feb; 85(3):1699-704. PubMed ID: 23289544
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Simultaneous monitoring of multiple attributes of pyrrolobenzodiazepine antibody-drug conjugates by size exclusion chromatography - high resolution mass spectrometry.
    Füssl F; Barry CS; Pugh KM; Chooi KP; Vijayakrishnan B; Kang GD; von Bulow C; Howard PW; Bones J
    J Pharm Biomed Anal; 2021 Oct; 205():114287. PubMed ID: 34385015
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Aldehyde tag coupled with HIPS chemistry enables the production of ADCs conjugated site-specifically to different antibody regions with distinct in vivo efficacy and PK outcomes.
    Drake PM; Albers AE; Baker J; Banas S; Barfield RM; Bhat AS; de Hart GW; Garofalo AW; Holder P; Jones LC; Kudirka R; McFarland J; Zmolek W; Rabuka D
    Bioconjug Chem; 2014 Jul; 25(7):1331-41. PubMed ID: 24924618
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Multi-step high-throughput conjugation platform for the development of antibody-drug conjugates.
    Andris S; Wendeler M; Wang X; Hubbuch J
    J Biotechnol; 2018 Jul; 278():48-55. PubMed ID: 29733878
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Characterization of Antibody-Drug Conjugate Pharmacokinetics and in Vivo Biotransformation Using Quantitative Intact LC-HRMS and Surrogate Analyte LC-MRM.
    Huang Y; Mou S; Wang Y; Mu R; Liang M; Rosenbaum AI
    Anal Chem; 2021 Apr; 93(15):6135-6144. PubMed ID: 33835773
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Middle-Down Multi-Attribute Analysis of Antibody-Drug Conjugates with Electron Transfer Dissociation.
    Chen B; Lin Z; Zhu Y; Jin Y; Larson E; Xu Q; Fu C; Zhang Z; Zhang Q; Pritts WA; Ge Y
    Anal Chem; 2019 Sep; 91(18):11661-11669. PubMed ID: 31442030
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Approaches to Interchain Cysteine-Linked ADC Characterization by Mass Spectrometry.
    Valliere-Douglass JF; Hengel SM; Pan LY
    Mol Pharm; 2015 Jun; 12(6):1774-83. PubMed ID: 25474122
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mass Spectrometry-Based Charge Heterogeneity Characterization of Therapeutic mAbs with Imaged Capillary Isoelectric Focusing and Ion-Exchange Chromatography as Separation Techniques.
    Wu G; Yu C; Wang W; Du J; Fu Z; Xu G; Li M; Wang L
    Anal Chem; 2023 Jan; 95(4):2548-2560. PubMed ID: 36656605
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Site-specific antibody-drug conjugates with variable drug-to-antibody-ratios for AML therapy.
    Dai Z; Zhang XN; Cheng Q; Fei F; Hou T; Li J; Abdolvahabi A; Watanabe J; Pei H; Smbatyan G; Xie J; Lenz HJ; Louie SG; Zhang Y
    J Control Release; 2021 Aug; 336():433-442. PubMed ID: 34197861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.